(Q39257411)

10 September 2017

In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours (English)

1 reference

10 September 2017

Raquel Muñoz

1

1 reference

10 September 2017

Yolanda Arias

2

1 reference

10 September 2017

José Miguel Ferreras

3

1 reference

10 September 2017

Pilar Jiménez

4

1 reference

10 September 2017

Carmen Langa

5

1 reference

10 September 2017

María Angeles Rojo

6

1 reference

10 September 2017

Manuel José Gayoso

7

1 reference

10 September 2017

Damián Córdoba-Díaz

8

1 reference

10 September 2017

Carmelo Bernabéu

9

1 reference

10 September 2017

Tomás Girbés

10

1 reference

10 September 2017

18 October 2012

1 reference

Cancer Immunology, Immunotherapy

10 September 2017

1 reference

10 September 2017

62

1 reference

10 September 2017

3

1 reference

10 September 2017

541-551

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1357-7

10 September 2017

0 references

cites work

Targeted therapies of cancer: angiogenesis inhibition seems not enough

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Anti-angiogenic therapy: adapting strategies to overcome resistant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Antibody drug-conjugates targeting the tumor vasculature: Current and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Leukemia regression by vascular disruption and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Neonatal hemolytic uremic syndrome after mother-to-child transmission of Escherichia coli O157.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

The physiological role of endoglin in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

The emerging role of TGF-beta superfamily coreceptors in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Transforming growth factor-beta and malignant melanoma: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Immunotoxin therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Vascular leak syndrome: a side effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Expression of normal and truncated forms of human endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Characterization of murine S-endoglin isoform and its effects on tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Fully human therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1357-7

10.1007/S00262-012-1357-7

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference